Treatment of visceral leishmaniasis (kala-azar) with aminosidine (= paromomycin)-antimonial combinations, a pilot study in Bihar, India
Authors:
- P. OlliaroPOP. Olliaro
- S. GothoskarSGS. Gothoskar
- S. BhowmickSBS. Bhowmick
- B.K. ChoudhuryBCB.K. Choudhury
- S. PrasadSPS. Prasad
- M. KumarMKM. Kumar
- B.B. VermaBVB.B. Verma
- 1 November 1992
- journal article
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 86 (6) , 615-616
Abstract
A 20 d drug regimen of aminosidine (= paromomycin) at 12 mg/kg/d in combination with sodium stibogluconate at 20 mg/kg/d proved efficacious and well-tolerated in patients with visceral leishmaniasis in the State of Bihar, India. Eighteen of 22 evaluable patients achieved an ultimate cure. The remaining 4 patients, although not cleared of parasites, had their parasite grade reduced and also improved clinically. This confirms prior findings in Kenyan patients with kala-azar, and indicates that this regimen is a valid alternative to antimonial compounds alone in the State of Bihar, where cases of kala-azar not responding to antimonial drugs and intolerant of pentamidine are increasingly recorded.Keywords
This publication has 5 references indexed in Scilit:
- Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United KingdomTransactions of the Royal Society of Tropical Medicine and Hygiene, 1992
- Comparison of Regimes of Treatment of Antimony-Resistant Kala-Azar Patients: A Randomized StudyThe American Journal of Tropical Medicine and Hygiene, 1991
- Treatment of visceral leishmaniasis in Kenya by aminosidine alone or combined with sodium stibogluconateTransactions of the Royal Society of Tropical Medicine and Hygiene, 1990
- Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised studyBMJ, 1988
- The effect of antibiotics of the neomycin group on experimental cutaneous leishmaniasisPathogens and Global Health, 1968